GlassScriptPhysician profile
Kevin Jwo
NPI 1346501137
$11,600.26
in general payments reported to CMS, 2019-2025
26 companies · $2,997 in 2025
The $2,997 reported for 2025 was more than what 91% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,809 · 2020: $570 · 2021: $673 · 2022: $941 · 2023: $3,483 · 2024: $1,127 · 2025: $2,997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,893 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,475 · Travel and Lodging: $1,230 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,893.04 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,475.00 |
| Travel and Lodging | $1,230.45 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $4,554.73 | 2019-2025 | Rocklatan, Clareon, Tryptyr |
| Biotissue Holdings INC. | $1,702.66 | 2024-2025 | |
| Abbvie INC. | $544.81 | 2022-2025 | |
| Allergan, INC. | $530.59 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $518.54 | 2019-2025 | Tecnis Simplicity, Tecnis Iol, Tecnis Iol |
| Aerie Pharmaceuticals, INC. | $506.05 | 2019-2021 | |
| Glaukos Corporation | $468.37 | 2019-2025 | Idosetr |
| New World Medical,INC. | $415.09 | 2019-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Oyster Point Pharma, INC. | $358.62 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Bausch & Lomb Americas INC. | $343.16 | 2023-2025 | Miebo, Xiidra, Scoutpro Osmolarity System |
| Sun Pharmaceutical Industries INC. | $285.96 | 2019-2025 | |
| Sight Sciences, INC. | $221.28 | 2019-2025 | Omni Surgical System |
| Thea Pharma INC. | $157.90 | 2022-2025 | Iyuzeh |
| Rxsight INC | $154.59 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Ivantis, INC | $139.56 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $127.75 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $122.59 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $118.24 | 2019-2020 | |
| Harrow Eye, LLC | $82.48 | 2025 | Vevye |
| Ocular Therapeutix, INC. | $53.35 | 2022 | |
| Amgen INC. | $47.63 | 2024-2025 | Tepezza |
| Horizon Therapeutics Plc | $40.06 | 2019-2022 | |
| Dutch Ophthalmic, USA | $38.39 | 2022 | |
| Nova Eye, INC. | $26.86 | 2024 | |
| Novartis Pharmaceuticals Corporation | $23.76 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Jwo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.